ArticleCureus2025
Condoliase Injection Therapy for Lumbar Disc Herniation With Incomplete Motor Deficits in a Professional Footballer: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although there are reports on good short-term outcomes of condoliase injection therapy for lumbar disc herniation (LDH), reports on the improvement of motor deficits, athlete-specific outcomes, or physiotherapy are lacking. We present a case of a 20-year-old male professional footballer who had low back pain, right gluteal pain, and numbness in the right lateral lower leg. The conservative treatment for L4/L5 disc herniation did not improve his symptoms, which were accompanied by incomplete motor deficits of the tibialis anterior (TA) and extensor hallucis longus (EHL) muscles. Thus, he was administered condoliase injection therapy. Approximately 13 weeks after the injection, his symptoms had completely disappeared, and his motor deficits had improved. After 14 weeks, the patient was able to return to competition. Condoliase injection therapy for athletes is one of the useful treatments with the potential to avoid surgery and return to competition, and it may also be effective for athletes with mild incomplete motor deficits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.